7  Multiple Outcomes and Totality of Evidence

Type of Assessment Assertion/Condition
Efficacy Mean blood pressure ↓ 5mmHg or exercise time ↑ 4m

Mean bp ↓ 5mmHg and ex time ↑ 4m

(Any mortality ↓ and ex time ↑ 4m) or mortality ↓ > 0.02

Improvement in any two of bp, ex time, LV function, or need for diuretics
Efficacy or non-inferiority Mortality ↓ or (mortality ↑ by < 0.02 and bp ↑ by < 3mmHg)
Risk/benefit Incidence of stroke ↓ and significant bleeding ↑ by factor < 1.1

7.1 Example: Acute Treatment of Migraine

  • Migraine: Developing Drugs for Acute Treatment, Oct. 2014 draft guidance
  • Demonstrate effect on 4 co-primary endpoints
    • pain
    • nausea
    • photophobia
    • phonophobia
  • More recently some consideration of having headache pain+nausea as co-primaries
    • or no headache pain at 2h and demonstrate effect on most bothersome migraine-associated symptom at 2h
    • nausea, phobias assessed as secondary endpoints
  • Let the targets be denoted by A,B,C,D
  • Hit all 4 targets: P(A and B and C and D)
  • Hit 2 and at least one other: P(A and B and (C or D))
  • Hit any 3: P(number of A, B, C, D ≥ 3)